申请人:Bayer Schering Pharma AG
公开号:US07776864B2
公开(公告)日:2010-08-17
Compounds of formula (I)
a tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the pyrimidine to which it is fused, R4, R5, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitors of the Pi3K/Akt pathway.
式(I)的化合物,其互变异构体或立体异构体,或其盐,其中环B和与其融合的嘧啶,R4、R5、R6和R7的含义如说明书和权利要求所述,是有效的Pi3K/Akt通路抑制剂。